Correlation Between Acrivon Therapeutics, and Rezolute

Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acrivon Therapeutics, Common and Rezolute, you can compare the effects of market volatilities on Acrivon Therapeutics, and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Rezolute.

Diversification Opportunities for Acrivon Therapeutics, and Rezolute

0.1

Correlation Coefficient

Acrivon Therapeutics,  Rezolute

Average diversification

The 3 months correlation between Acrivon and Rezolute is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Rezolute go up and down completely randomly.

Pair Corralation between Acrivon Therapeutics, and Rezolute

Given the investment horizon of 90 days Acrivon Therapeutics, is expected to generate 1.15 times less return on investment than Rezolute. In addition to that, Acrivon Therapeutics, is 1.14 times more volatile than Rezolute. It trades about 0.04 of its total potential returns per unit of risk. Rezolute is currently generating about 0.05 per unit of volatility. If you would invest  452.00  in Rezolute on July 19, 2024 and sell it today you would earn a total of  43.00  from holding Rezolute or generate 9.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Acrivon Therapeutics, Common  vs.  Rezolute

Acrivon Therapeutics,

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Acrivon Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Acrivon Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in November 2024.

Rezolute

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Rezolute are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Rezolute unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Acrivon Therapeutics, and Rezolute

The main advantage of trading using opposite Acrivon Therapeutics, and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.

The idea behind Acrivon Therapeutics, Common and Rezolute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.